Webinar: Saudi Arabia – A Vital Middle East Hub for Clinical Trials

Global clinical trials are moving through one of their most unsettled phases to date. Escalating costs, evolving regulatory frameworks, geopolitical uncertainty, and increasingly intricate study designs are redefining how research is conducted worldwide. Sponsors are under growing strain, from data-intensive protocols and limited patient availability to supply chain disruption and policy shifts that put R&D investment at risk.

Against this backdrop, Saudi Arabia is emerging with resilience as the Middle East’s largest pharmaceutical market, while rapidly strengthening its position within the global clinical research ecosystem.

Join Zayheda Khan, Oximio’s Chief Commercial Officer and Günes Yildirim, Regional Director for MENA as they examine the key economic forces, market developments, and strategic opportunities driving Saudi Arabia’s rise as a key hub for clinical trials in the Middle East.

A must-attend webinar for those planning or running clinical trials in the Middle East, the webinar delivers practical insights and expert guidance to help navigate logistical challenges within the region.

Sign up now: https://www.arena-international.com/event/saudi-arabia-a-vital-middle-east-hub-for-clinical-trials/